DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pharmacometabolomics
Pharmacometabolomics
A Targeted Neurotransmitter Quantification and Nontargeted
Metabolomics Profiling and Pathway Analysis of Human Plasma and Urine T Reveal Further Insights Into the Multifactorial Nature of Coronary Artery Disease ⁎ ⁎ Arwa M
Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway
Review Article the Use of Omic Technologies Applied to Traditional Chinese Medicine Research
Mass Spectrometry-Based Applications and Analytical Method Development for Metabolomics
Novel Applications of Metabolomics in Personalized Medicine: a Mini-Review
Pharmacometabolomics in Drug Discovery & Development: Applications and Challenges Z
Pharmacometabolomics Informs Viromics Toward Precision Medicine
Binding Sites Influence AHR Ligand–Dependent Gene Expression S
File Download
Omics-Based Biomarkers: Current Status and Potential
NMR Based Pharmaco-Metabolomics: an Efficient and Agile Tool for Therapeutic Evaluation of Traditional Herbal Medicines
Mass Spectrometry-Based Metabolomics: a Guide for Annotation, Quantification and Best Reporting Practices
UHPLC–MS/MS-Based Nontargeted Metabolomics Analysis Reveals Biomarkers Related to the Freshness of Chilled Chicken
Precision Medicine: from Pharmacogenomics to Pharmacoproteomics
Metabolomics Community in Russia: History of Development, Key Participants, and Results
Pilot Study of Metabolomic Clusters As State Markers of Major Depression and Outcomes to CBT Treatment
Towards Personalized Drug Therapy
Top View
Metabolomics Enables Precision Medicine
Applications of Liquid Chromatography Coupled to Mass Spectrometry-Based Metabolomics in Clinical Chemistry and Toxicology: a Review
Prediction of Clinical Outcomes After SSRI Therapy for Major Depressive Disorder Using Clinical and Metabolomics Data: a Data-Driven Machine Learning Approach
Pharmacometabolomics: a New Horizon in Personalized Medicine
A Metabolome-Wide Association Study in the General Population Reveals Decreased Levels of Serum Laurylcarnitine in People with Depression
Towards Personalized Drug Therapy
Pharmacometabolomics Informs Pharmacogenomics
TSPAN5, ERICH3 and Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder: Pharmacometabolomics- Informed Pharmacogenomics
Pharmacometabolomics and Precision Medicine Special Issue Editorial
Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine